By Brooke Hudspeth, Pharm.D. University of Kentucky You’ve likely heard about glucagon-like peptide-1 agonists – usually ...

An increasingly popular class of drugs is just one of the factors fueling the sticker shock. Two generations are making a ...

CHICAGO — New research is showing certain weight loss drugs could be linked to eye related issues. A couple studies published ...

GLP-1 receptor agonists like semaglutide and the dual GIP/GLP-1 agonist tirzepatide mimic naturally occurring hormones that regulate blood sugar, appetite, and digestion. GLP-1 (glucagon-like ...

Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.

An increasing popular class of drugs is a big driver of the expected higher costs. Two generations are making a risky bet on ...

Ozempic a brand name for semaglutide works by mimicking a natural hormone that helps your body regulate blood sugar reduce ...

With anti-obesity drugs like semaglutide set to drop in price from a staggering Rs 30,000 to just Rs 3,000 per month, ...

When researchers tested the amount of force exerted by mice, they found that some showed a decrease in strength, despite ...

Novo Nordisk's FY 2025 guidance cuts are driven by softer U.S. Wegovy/Ozempic and GLP-1 trends. Click here to find out why I ...

Research suggests Ozempic may weaken muscles even when they don’t shrink, with most lean mass loss coming from organ size ...

Tirzepatide (GIP + GLP-1) has also been shown to reduce cardiovascular risk. In an international trial of 713 adults in nine ...